Live Breaking News & Updates on Dementia discovery fund

Stay informed with the latest breaking news from Dementia discovery fund on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dementia discovery fund and stay connected to the pulse of your community

Harness Therapeutics appoints experienced biopharma exec as Chair

Experienced biopharma executive Meenu Chhabra Karson has been appointed Chair of the Board at Cambridge-based Harness Therapeutics.

Babraham , Cambridgeshire , United-kingdom , Jan-thirkettle , Chhabra-karson , Audit-committee-of-fore-bio , Audit-committee-of-vallon , Dementia-discovery-fund , Novartis , Allozyne-inc , Vp-business-development , Babraham-research-campus

A dementia-focused VC digs past amyloid for new kinds of brain drugs

BioPharma

Jonathan-behr , Eli-lilly , Therini-bio , Eisai-leqembi , Amgen , Merck-co , Sv-health-investors , Pfizer , Dementia-discovery-fund , Caraway-therapeutics , Biotech ,

Lose Fat, Not Muscle: Next Test for Lilly's Zepbound Pairs It With BioAge Drug

In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.

Cambridge , Cambridgeshire , United-kingdom , Redwood-city , California , United-states , Columbus , Ohio , Chapel-hill , Thousand-oaks , Delaware , Deerfield

Sudo raises $147M to advance 2 TYK2 inhibitor therapies to trials

Sudo raises $147M to advance 2 TYK2 inhibitor therapies to trials
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Juergen-eckhardt , Sudo-biosciences , Jonathan-behr , Matthias-kleinz , Scott-byrd , Dementia-discovery-fund , Sv-health-investors-fund , Bayer-ag , Translational-sciences-investments , Enavate-sciences , Rise-fund , Sv-health-investors

Exclusive: What Y Combinator partner Dalton Caldwell is looking for, as YC releases new 'Requests for Startups'

For the first time in almost six years, Y Combinator is extensively outlining 20 new categories of startups they’re interested in seeing.

Irvine , California , United-states , Spain , San-diego , Israel , Helsinki , Eteläuomen-läi , Finland , Coatue , Massachusetts , Tel-aviv

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round

The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...

London , City-of , United-kingdom , Boston , Massachusetts , United-states , British , Matthias-kleinz , Sudo-bioscience , Juergen-eckhardt , Scott-byrd , Sudo-biosciences

Anika Heavener, Author at MedCity News

Anika Heavener, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United-states , Americans , Anika-heavener , Dementia-discovery-fund , Vice-president , Mass-general , Weight-loss , Besity , Verweight , Diabetes , Massachusetts , Medical-devices

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, is today hosting a Research & Development (R&D) Day for investors and analysts in New York to provide clinical updates for BT8009, BT748

Santiago , Regióetropolitana , Chile , United-kingdom , New-york , United-states , Cambridge , Cambridgeshire , Kevin-lee , Drug-administration , Dementia-discovery-fund , Research-development-rd-day

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Nectin-4 portfolio comprised of BT8009 and BT7480 represents potential opportunity to become leader in treating Nectin-4-driven cancers, starting with metastatic urothelial cancer

Updated BT8009...

Santiago , Regióetropolitana , Chile , United-kingdom , New-york , United-states , Cambridge , Cambridgeshire , Kevin-lee , Exchange-commission , Research-development-rd-day , Drug-administration

Bicycle Therapeutics Plc (BCYC) Provides Data Updates for Three Clinical Programs and Strategy Overview

Bicycle Therapeutics Plc (BCYC) Provides Data Updates for Three Clinical Programs and Strategy Overview
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Santiago , Regióetropolitana , Chile , New-york , United-states , Kevin-lee , Dementia-discovery-fund , Drug-administration , Research-development-rd-day , Bicycle-therapeutics , Nobel-prize-winning , Santiago-arroyo